These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31965362)

  • 41. Long-term outcomes of combined endoscopic resection and chemoradiotherapy for esophageal squamous cell carcinoma with submucosal invasion.
    Yoshimizu S; Yoshio T; Ishiyama A; Tsuchida T; Horiuchi Y; Omae M; Hirasawa T; Asari T; Chin K; Fujisaki J
    Dig Liver Dis; 2018 Aug; 50(8):833-838. PubMed ID: 29477349
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term outcomes of multimodal therapy combining definitive chemoradiotherapy and salvage surgery for T4 esophageal squamous cell carcinoma.
    Sugawara K; Yagi K; Okumura Y; Nishida M; Aikou S; Yamashita H; Yamashita H; Seto Y
    Int J Clin Oncol; 2020 Apr; 25(4):552-560. PubMed ID: 31828451
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term outcomes of salvage endoscopic submucosal dissection for local failure after chemoradiotherapy for esophageal squamous cell carcinoma.
    Kimura H; Yoshida M; Yabuuchi Y; Kakushima N; Yamamoto Y; Kawata N; Takizawa K; Kishida Y; Imai K; Ito S; Hotta K; Ishiwatari H; Matsubayashi H; Ono H
    Jpn J Clin Oncol; 2021 Jul; 51(7):1036-1043. PubMed ID: 33758950
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Salvage lymphadenectomy versus salvage radiotherapy/chemoradiotherapy for recurrence in cervical lymph node after curative resection of esophageal squamous cell carcinoma.
    Ma X; Zhao K; Guo W; Yang S; Zhu X; Xiang J; Zhang Y; Li H
    Ann Surg Oncol; 2015 Feb; 22(2):624-9. PubMed ID: 25155397
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Locoregional Recurrence of Esophageal Cancer Treated with Curative Intent Local Salvage Therapy: A Single Center Experience.
    Grou-Boileau F; Tankel J; Nevo Y; Najmeh S; Spicer J; Cools-Lartigue J; Mueller C; Ferri L
    J Gastrointest Cancer; 2023 Dec; 54(4):1292-1299. PubMed ID: 36988820
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Salvage photodynamic therapy for local failure after chemoradiotherapy for esophageal squamous cell carcinoma.
    Hatogai K; Yano T; Kojima T; Onozawa M; Daiko H; Nomura S; Yoda Y; Doi T; Kaneko K; Ohtsu A
    Gastrointest Endosc; 2016 Jun; 83(6):1130-1139.e3. PubMed ID: 26608125
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumor response and survival outcomes of salvage concurrent chemoradiotherapy with three-dimensional conformal radiotherapy and 5-fluorouracil/platinum-based chemotherapy for postoperative locoregional recurrence of esophageal squamous cell carcinoma.
    Ito R; Nakamura Y; Sunakawa H; Fujiwara H; Hojo H; Nakamura N; Fujita T; Yano T; Daiko H; Akimoto T; Yoshino T; Kojima T
    Esophagus; 2022 Oct; 19(4):645-652. PubMed ID: 35900683
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validity of Surgical Resection for Lymph Node or Pulmonary Recurrence of Esophageal Cancer After Definitive Treatment.
    Shimada A; Tsushima T; Tsubosa Y; Booka E; Takebayashi K; Niihara M; Isaka M; Ohde Y; Machida N; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
    World J Surg; 2019 May; 43(5):1286-1293. PubMed ID: 30675631
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radiotherapy and chemoradiotherapy for postoperative recurrence in patients with esophageal squamous cell carcinoma.
    Liu Q; Tu XH; Yu RX; Wen HY; Guo XG; Ma DY; Jiang KY; Tian D
    Cancer Med; 2024 Aug; 13(16):e70108. PubMed ID: 39161098
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Post-esophagectomy Adjuvant Chemotherapy Benefits Esophageal Cancer Patients.
    Sohda M; Saito H; Kuriyama K; Yoshida T; Kumakura Y; Honjyo H; Hara K; Ozawa D; Suzuki S; Tanaka N; Sakai M; Miyazaki T; Fukuchi M; Kuwano H
    In Vivo; 2019; 33(2):501-506. PubMed ID: 30804133
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of transthoracic esophagectomy with definitive chemoradiotherapy as initial treatment for patients with esophageal squamous cell carcinoma who could tolerate transthoracic esophagectomy.
    Matsuda S; Tsubosa Y; Niihara M; Sato H; Takebayashi K; Kawamorita K; Mori K; Tsushima T; Yokota T; Ogawa H; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
    Ann Surg Oncol; 2015; 22(6):1866-73. PubMed ID: 25564176
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
    Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retrospective analysis of neoadjuvant chemotherapy followed by surgery versus definitive chemoradiotherapy with proton beam for locally advanced esophageal squamous cell carcinoma.
    Ogawa K; Ishikawa H; Hisakura K; Hiroshima Y; Moriwaki T; Yamada T; Yamamoto Y; Akashi Y; Owada Y; Ohara Y; Enomoto T; Furuya K; Doi M; Shimomura O; Takahashi K; Hashimoto S; Sakurai H; Oda T
    Int J Clin Oncol; 2021 Oct; 26(10):1856-1863. PubMed ID: 34241725
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical outcomes according to the modified endoscopic criteria for neoadjuvant chemotherapy in resectable esophageal squamous cell carcinoma.
    Kadota T; Abe S; Yoda Y; Yoshinaga S; Oda I; Kojima T; Kato K; Daiko H; Yano T
    Dig Endosc; 2020 Mar; 32(3):337-345. PubMed ID: 31295769
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Associated factors of postoperative relapse and metastasis in pT1bN0M0-pT4aN0M0 thoracic esophageal squamous cell carcinoma].
    Pan W; Xiang Y; Gu Z; Ji C; Mao T; Fang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1045-1049. PubMed ID: 28900998
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Definitive salvage radiation therapy and chemoradiation therapy for lymph node oligo-recurrence of esophageal cancer: a Japanese multi-institutional study of 237 patients.
    Yamashita H; Jingu K; Niibe Y; Katsui K; Matsumoto T; Nishina T; Terahara A
    Radiat Oncol; 2017 Feb; 12(1):38. PubMed ID: 28219406
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical outcome of endoscopic mucosal resection for esophageal squamous cell cancer invading muscularis mucosa and submucosal layer.
    Yoshii T; Ohkawa S; Tamai S; Kameda Y
    Dis Esophagus; 2013 Jul; 26(5):496-502. PubMed ID: 22676622
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term survival after definitive proton beam therapy for oligorecurrent esophageal squamous cell carcinoma: a case report.
    Ishikawa Y; Suzuki M; Yamaguchi H; Seto I; Machida M; Takagawa Y; Jingu K; Kikuchi Y; Murakami M
    J Med Case Rep; 2022 Feb; 16(1):68. PubMed ID: 35152904
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term results of concurrent chemoradiotherapy with daily-low-dose continuous infusion of 5-fluorouracil and cisplatin (LDFP) for Stage I-II esophageal carcinoma.
    Kumabe A; Fukada J; Kota R; Koike N; Shiraishi Y; Seki S; Yoshida K; Kitagawa Y; Shigematsu N
    Dis Esophagus; 2018 Apr; 31(4):. PubMed ID: 29228166
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimal preoperative neoadjuvant therapy for resectable locally advanced esophageal squamous cell carcinoma.
    Leng XF; Daiko H; Han YT; Mao YS
    Ann N Y Acad Sci; 2020 Dec; 1482(1):213-224. PubMed ID: 33067818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.